Head-to-head comparison
Navio MD vs Sprout Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo).
$345/mo (brand-name) sema · From $189/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Not available in Alabama and Mississippi
Desk Score
A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
$299/mo sema · $349/mo tirz · Verified August 2026
Marked down on: FDA issued Sprout Health Partners LLC dba Sprout Health a warning letter in September 2025; the letter is public in FDA's warning-letter database
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Sprout Health takes this head-to-head with the higher Desk Score, 86/100 (B) against 79/100 (C+) for Navio MD. Navio MD still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Navio MD
79/100
C+
Sprout Health
86/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Navio MD | Sprout Health |
|---|---|---|
| Semaglutide | $345/mobrand-name$345/mo (starting dose, brand-name) | $299/mo$299/mo month-to-month (compounded; $149 for the first month with code FIRST150; monthly, 3-month or 6-month subscriptions) — brand Wegovy from $1,799/mo |
| Tirzepatide | From $189/molowest dose rung$189/mo (starting dose, compounded) | $349/mo$349/mo month-to-month (compounded; $199 for the first month, which is the same $150 off) — brand Zepbound from $1,999/mo |
| Coverage | 48 states | Not listed on Sprout Health's site (checked August 2026) |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Compounded tirzepatide with brand-name fallback across 48 states. | Patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding. |
| Desk Score | 79/100C+ | 86/100B |
The verdict
Desk pick — Sprout HealthSprout Health takes this head-to-head with the higher Desk Score, 86/100 (B) against 79/100 (C+) for Navio MD. Navio MD still holds its ground where its strengths line up with yours.
Choose Navio MD if…
Compounded tirzepatide with brand-name fallback across 48 states.
$345/mo (brand-name) sema · From $189/mo (lowest dose rung) tirz · 48 states
Choose Sprout Health if…
Patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding.
$299/mo sema · $349/mo tirz
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Navio MD · Sprout Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Navio MD
- CoreAge Rx vs Sprout Health
- AskRx vs Navio MD
- Sprout Health vs Vytora Health
- Better U Care vs Navio MD
- Amazon One Medical vs Sprout Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.